Filing Details

Accession Number:
0001209191-20-010560
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-19 16:39:59
Reporting Period:
2020-02-17
Accepted Time:
2020-02-19 16:39:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1789815 Ourania Tatsis C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Svp, Cro No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-02-17 597 $241.50 16,349 No 4 F Direct
Common Stock Disposition 2020-02-18 160 $241.82 16,189 No 4 S Direct
Common Stock Disposition 2020-02-18 528 $242.78 15,661 No 4 S Direct
Common Stock Disposition 2020-02-18 160 $243.78 15,501 No 4 S Direct
Common Stock Disposition 2020-02-18 286 $244.99 15,215 No 4 S Direct
Common Stock Disposition 2020-02-18 145 $245.75 15,070 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $241.82 (range $241.33 to $242.18).
  3. Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $242.78 (range $242.38 to $243.31).
  5. Open market sales reported on this line occurred at a weighted average price of $243.78 (range $243.42 to $244.23).
  6. Open market sales reported on this line occurred at a weighted average price of $244.99 (range $244.52 to $245.30).
  7. Open market sales reported on this line occurred at a weighted average price of $245.75 (range $245.54 to $245.85).